Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ruzsics, S. Singoszki, B. Illés M., V. Sárosi, Z. Balikó, M. Tokés-Füzsi, T. Koszegi, G. Woth, I. Vermes, G. L. Kovács (Pécs, Hungary). Microparticles in stable and exacerbated COPD patients. Eur Respir J 2013; 42: Suppl. 57, 777

Member's Comments

No comment yet.

Related content which might interest you: Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Falls, an underestimated risk in COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013